Also, GCN5 regulates pathological cardiac hypertrophy in rat cardiomyocytes and mouse models via facilitation of the transforming growth factor β activated kinase 1 (TAK1)/c-Jun N-terminal kinase (JNK)/p38 signaling 40. Here, MAPK14 is linked to cardiac hypertrophy.